This therapy is purely Blood-Derived and minimally invasive. Follow-up treatments may need to be performed more often for optimal results.
The Blood-Derived Therapy is performed in a clinical outpatient setting over the course of two days. After the Lung Institute’s medical staff has determined that a patient is a candidate for treatment, he or she will be asked to fill out all of the required paper work. A pulmonary function test will be performed, and the patient will go through a preparation process. Following the insertion of an IV, the blood cells are harvested, processed and separated and then immediately returned to the patient’s body intravenously where they may promote healing. This process is also repeated on day two of the patient’s treatment program. This minimally invasive procedure has proven to be a viable option for many patients with chronic obstructive pulmonary disease (COPD). At the end of day two, the overseeing physician will do a thorough evaluation of the patient’s treatment and prep him or her for follow-up care.
The patient will receive follow up care at the two-week, three-month and six-month mark following his or her treatment. The patient is encouraged to return for a follow-up appointment with his or her pulmonologist at the three-month mark.
- Pulmonary fibrosis causes scar tissue to form in the lungs’ air sacs, making it more difficult for the lungs to deliver oxygen to the bloodstream. A type of interstitial lung ... Read more
- A featured series where Lung Health Institute employees tell their stories #WhatIsMyWhy My mother’s been dealing with pulmonary fibrosis, and she has a autoimmune disease. Her treatment gives her little to no ... Read more